Research At Alivation
Dr. Walt Duffy, Founder and Medical Director of Alivation Research, has been the principal investigator on over 150 clinical trials since 2005. Alivation could not have done it without the participation of the general public. Take a look at our current studies to see if you are eligible to participate.
ABOUT US
Who Are We?
Alivation Research takes part in research studies that help further science and medicine, and we are looking for qualified candidates to help. Our goal is to measure results and to determine the safety and tolerability of treatment options. Research makes it possible for our patients to access the newest treatments when traditional treatments may not be working. Participants are often compensated for their time and travel and receive their study medication and devices at no cost.
What do you get out of it?
Compensation from our research sponsors.
Some healthcare (study medication)
for free.
A feeling that you have participated in something meaningful.
A chance to help science, yourself, & others
What Studies Do We Currently Offer?
We offer both adult and pediatric study trials. They each have their own distinct requirements. Be sure to read the description carefully. Then complete the form below to contact us and receive more information about joining a study.
Adult Studies
Study Number 1 Indication: Early Alzheimer's Disease Investigational Product: Sildenafil Age: 55 to 90 Compensation: $975 (max)
Study Number 2 Indication: Adults with Alzheimer's Disease with Psychosis Investigational Product: ALP-204 Age: 55 to 95 Patient Compensation: $1767 (max) Caregiver Compensation: $1326 (max)
Study Number 3 Indication: Treatment Resistant Depression Investigational Product: Comp 360 (synthetic psilocybin) Age: 19 or older Compensation: $1,300 (max)
Study Number 4 Indication: Tardive Dyskinesia Investigational Product: Valbenazine Age: 19 or older Compensation: $100 per visit
Study Number 5: Indication: Bipolar Disorder Investigational Product: Vagus Nerve Stimulator Age: 19 or older Compensation: Up to $2,300
Pediatric Studies
Study Number #10 Indication: Meningococcal Disease Investigational Product: Meningitis Vaccine Age: 10 to 17 Compensation: $2230 (max)
Study Number #11 Indication: Tourette's Disorder Investigational Product: Ecopipam Age: 6 to 18 Compensation: $75 per visit
Study Number #12 Indication: ADHD Investigational Product: Centanafadine Age: 4 to 17 Compensation: $53 per visit
Study Number #13 Indication: ADHD Investigational Product: Azstarys Age: 4 to 12 Compensation: $300 (max)
Study #14 Indication: Pediatric Schizophrenia Investigational Product: Olanzapine Ages: 13 to 18 Compensation: $2100 (max)
Study #15 Indication: Pediatric Bipolar1 Investigational Product: Olanzapine Ages: 10 to 18 Compensation: $2100 (max)
Study #16 Indication: Autism Spectrum Disorder Investigational Product: Cariprazine Ages: 5 to 17 Compensation: $900 (max)
Want to Join a Study?
If you think that you fit any of the requirements for our research studies fill out this form below, which will then be sent to us for review. If you qualify for the research study, we will have a member of our team get back to you on the next steps. To expedite the process, please print the ROI Form and have your healthcare professional complete it.
For Sponsors/CRO's
If you are looking to work with Alivation Research. Please fill out and submit this form.
